GlassScriptPhysician profile
Praveen K Suchdev
NPI 1023049814
$72,260.70
in general payments reported to CMS, 2019-2025
19 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,709 · 2020: $4,818 · 2021: $12K · 2022: $17K · 2023: $12K · 2024: $12K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $6,042 · Travel and Lodging: $4,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,937.50 |
| Food and Beverage | $6,041.89 |
| Travel and Lodging | $4,207.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $64,565.98 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, General - Pain Management |
| Spinal Simplicity, LLC | $2,933.51 | 2023-2024 | Ha Minuteman G3-R, Liberty Si |
| Vertiflex, INC. | $1,072.58 | 2019 | |
| Abbott Laboratories | $894.03 | 2019-2025 | Eterna, Proclaim |
| Pacira Pharmaceuticals Incorporated | $828.21 | 2024-2025 | Iovera |
| Painteq LLC | $403.73 | 2021-2024 | Painteq |
| Si-Bone, INC. | $360.21 | 2022 | |
| Spr Therapeutics, INC | $257.73 | 2024 | Sprint Pns System |
| Neuronetics, INC. | $236.92 | 2021-2022 | |
| Curonix LLC | $152.67 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $115.81 | 2019-2025 | Belbuca, Xtampza |
| Janssen Pharmaceuticals, INC | $97.79 | 2025 | Spravato |
| Stimwave Technologies Incorporated | $80.92 | 2020 | |
| Novartis Pharmaceuticals Corporation | $64.26 | 2019 | |
| Abbvie INC. | $56.52 | 2023-2025 | Qulipta |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $49.15 | 2019-2020 | |
| Pfizer INC. | $46.41 | 2019 | |
| Medtronic, INC. | $25.72 | 2021 | |
| Grt US Holding, INC. | $18.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Praveen Suchdev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.